Study on apoE gene polymorphism and subclasses of serum high density lipoprotein in type IV hyperlipidemia

Chinese Journal of Medical Genetics

Volumn 22, Issue 1, 2005, Pages 96-98

  Tian, Ying ^a   Long, Shi Yin ^b   Xu, Yan Hua ^c   Fu, Ming De ^a   Zhang, Xue Mei ^a   Liu, Bing Wen ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c Hoist Group Post Doctor Work Station   (China)

Author keywords

Apolipoprotein E; Genotype; High density lipoprotein subclasses; Polymerase chain reaction restriction fragment length polymorphism; Type IV hyperlipidemia

Indexed keywords

APOLIPOPROTEIN C; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERLIPIDEMIA TYPE 4; IMMUNODETECTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; APOLIPOPROTEIN C-III; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES;

EID: 13544271856     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Xu YH, Fu MD. Alterations of HDL subclasses in hyperlipidemia. Clini Chimi Acta, 2003, 332: 95-102.
2. Asztalos BF, Schaefer EJ. High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol, 2003, 91: 12E-17E.
3. Asztalos BF, Roheim PS, Milani R, et al. Distribution of apoAI-containing HDL subpopulations in patients with coronary heart disease. Aterioscler Thromb Vasc Biol, 2000, 20: 2670-2676.
4. Luthra K, Bharghav B, Chabbra S, et al. Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins. Mol Cell Biochem, 2002, 232: 97-102.
5. Ashavaid TF, Todur SP, Nair KG. Apolipoprotein E polymorphism and coronary heart disease. J Assoc Physicians India, 2003, 51: 784-788.
6. Zhang XM, Liu BW, Bai H, et al. Study on apoE gene polymorphism in Chinese endogenous hypertriglyceridemia. Chin J Med Genet, 2001, 18: 100-104.
7. Wu XW, Fu MD, Liu BW, et al. The immunodetection method of high density lipoprotein subclasses in human serum. Chin J Arterioscler, 1999, 7: 253-255.
8. Larson IA, Ordovas JM, DeLuca C, et al. Association of apolipoprotein (Apo) E genotype with plasma apo E levels. Atherosclerosis, 2000, 148: 327-335.
9. Albers JJ, Pitman W, Wolfbause G, et al. Relationship between phospholipid transfer proteinactivity and HDL level and size among inbred mouse strains. J Lipid Res, 1999, 40: 295-301.
10. de Beer F, van Dijk KW, Jong MC, et al. Apolipoprotein E2 (Lys146 → Gln) causes Hypertriglyceridemia due to an Apolipoprotein E Variant-Specific Inhibition of lipolysis of Very Low Density Lipoproteins-Triglycerides. Arterioscl Thromb Vasc Bio, 2000, 20: 1800-1806.
11. Dallongeville J, Lussier-Cacan S, Davignon J, et al. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res, 1992, 33: 447-454.
12. McGladderya SH, Frohlicha JJ. Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy. J Lipid Res, 2001, 42: 1905-1912.